ArticleSleep science (Sao Paulo, Brazil)
Effects of the mandibular advancement device on daytime sleepiness, quality of life and polysomnographic profile of public transport drivers with obstructive sleep apnea syndrome.
Article in Sleep science (Sao Paulo, Brazil). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 1 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo evaluate the effects of the mandibular advancement device (MAD) on daytime sleepiness, quality of life (QoL) and polysomnographic profile of intercity transport drivers with obstructive sleep apnea syndrome (OSAS). MATERIAL AND
methodsA quasi-experimental study evaluating intercity transport drivers from March to September 2019. The apnea-hypopnea index (AHI) was evaluated by type III polysomnography, which defined the severity of the disease. OSAS: mild (5 to 15), moderate (15 to 29), or severe (= 30). Sleepiness was assessed using the Epworth sleepiness scale, consisting of 8 questions about the likelihood of drowsiness in daily situations. QoL was assessed using the SF-36 questionnaire, which provides the score in eight domains: functional capacity, physical aspects, pain, general health status, vitality, social aspects, emotional aspects, and mental health. Drivers with OSAS underwent intervention with application of personalized MAD for 8 to 12 weeks.
resultsThe total sample (n=23) (44.77±11.56 years) had a body mass index (BMI) of 30.64±4.66kg/m2, and an OSAS prevalence of 65.2% of drivers (n=15). There were losses of 4 drivers so that the final sample of drivers with OSAS for the intervention with the MAD was 11 individuals, with an average age of 45.54±9.41 years and BMI of 32.21±3.17kg/m². There was a decrease in AHI (28.51±15.66ev/h 012.11±6.70ev/h, p=0.002) and pain (60 (50-60)040 (40-50), p=0.015) after the intervention.
conclusionThere was a reduction in AHI in intercity transport drivers after implementing the MAD procedure.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.